DIA 2024 Global Annual Meeting

June 16-20, 2024  |  San Diego, CA

The DIA 2024 Global Annual Meeting invites industry, regulators, governments, academics, innovators, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in San Diego, DIA 2024 will amplify different perspectives while highlighting expertise across the globe to reimagine current processes that better enhance health and well-being.

Join Avoca for the following session:

Tuesday, June 18  •  8:00am – 9:00am PDT

Feasible Site Feasibility Assessments: Rethinking Business as Usual to Reduce Burden, Timelines, and Costs for Sustainability

In 2021, recommendations to reduce site feasibility assessment burdens was released. Current industry and CRO methods remain costly and inefficient, and delay trial start-up and patient access to clinical trials.

Learning Objectives:

• Describe the impact of non-standardized study feasibility assessments across the industry
• Discuss opportunities and solutions around improvements to the site feasibility assessment process
• Apply new methods to streamline feasibility assessments and improve study start-up timelines

Chair:

• Trevor Cole, MBA, RN, PMP
  Associate Director, Client Delivery
  WCG

Panelists:

• Kristen Ballesteros, PhD, MS
  Associate Director, Feasibility Strategy
  Thermo Fischer Scientific, PPD
• Suanna Bruinooge, MPH
  Chief and Division Director, Research Strategy and Operations Center
  American Society of Clinical Oncology
• Ramya Thota
  Associate Professor
  Intermountain Medical Oncology – IMC

Visit WCG at booth #1126 or contact us to schedule an on-site meeting.

RELATED CONTENT: